FDA approval for Ozempic is based on the results of the SUSTAIN 6 Cardiovascular Outcome Trial (CVOT), which assesses the cardiovascular safety of adding Ozempic or placebo to standard treatment for adults with type 2 diabetes and diagnosed cardiovascular disease
Received a diagnosis of gastroparesis, stomach paralysis, gastric obstruction, ileus, or intestinal pseudo-obstruction while taking these drugs or within 30 days of stopping use
This dramatically slows degradation, preserving potency for months or even years
Get the details in the Diabetes section of our Protein Powders and Shakes Review
Mary Claire Haver, where she continues the conversation on womens health, empowerment, and evidence-based care
Association between urinary sodium and potassium excretion and blood pressure among adults in the United States: National Health and Nutrition Examination Survey, 2014